Journal of Chromatography B, Journal Year: 2024, Volume and Issue: 1252, P. 124445 - 124445
Published: Dec. 28, 2024
Language: Английский
Journal of Chromatography B, Journal Year: 2024, Volume and Issue: 1252, P. 124445 - 124445
Published: Dec. 28, 2024
Language: Английский
Carbohydrate Polymers, Journal Year: 2025, Volume and Issue: 356, P. 123387 - 123387
Published: Feb. 16, 2025
Language: Английский
Citations
1International Journal of Biological Macromolecules, Journal Year: 2024, Volume and Issue: unknown, P. 136691 - 136691
Published: Oct. 1, 2024
Language: Английский
Citations
5International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 141566 - 141566
Published: Feb. 1, 2025
Language: Английский
Citations
0ACS Nano, Journal Year: 2025, Volume and Issue: unknown
Published: March 19, 2025
Excessive reactive oxygen species, disruption of the epithelial barrier, immune dysregulation, and gut microbiota imbalance are key factors driving onset inflammatory bowel disease (IBD) complicating its treatment. Prompt diagnosis diseases precise delivery therapeutic agents to inflamed intestinal sites offer promising targeted strategies for effectively treating IBD. Here, a barium sulfate-based nanoplatform (BaSO4@PDA@CeO2/DSP, BPCD) synergistic nanozymes drugs was developed. With enhanced colonic retention after oral drug delivery, this enables effective targeting CT imaging guidance address multiple contributing A comprehensive effect achieved through action cerium oxide with optimized Ce3+/Ce4+ ratio sustained release dexamethasone sodium phosphate. Benefiting from superior gastrointestinal stability, is highly in IBD by alleviating oxidative stress, modulating macrophage polarization balance, flora composition, repairing barrier. BPCD inhibits development mechanisms has biocompatibility, emerging as practical alternative traditional therapies.
Language: Английский
Citations
0Journal of Affective Disorders, Journal Year: 2025, Volume and Issue: unknown
Published: March 1, 2025
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 142789 - 142789
Published: April 1, 2025
Language: Английский
Citations
0Journal of Agricultural and Food Chemistry, Journal Year: 2025, Volume and Issue: unknown
Published: April 24, 2025
Ulcerative colitis (UC) is a chronic inflammatory bowel disease with rising incidence globally, whereas existing treatments exhibit significant limitations. Coix seed polysaccharide (CSP), component of traditional Chinese medicine known for its immunomodulatory and antioxidant properties, has not been thoroughly investigated role in UC. In this study, CSP was prepared via water extraction ethanol precipitation, protective effects mechanisms were evaluated using dextran sulfate sodium salt (DSS)-induced UC mouse model. The results demonstrated that significantly ameliorated DSS-induced symptoms, including weight loss, an elevated Disease Activity Index, colon shortening, increased levels cytokines, intestinal barrier damage. Moreover, reshaped the gut microbiota dysbiosis by increasing microbial diversity regulating abundance specific genera, such as Anaerotruncus. Metabolomic analysis revealed modulated 116 metabolites, particularly enhancing beneficial metabolite 3-hydroxybutyrate. Importantly, preventive effect on dependent could be transferred fecal transplantation. This study demonstrates CSP, microecology-regulating polysaccharide, effectively modulates alleviates symptoms These findings support potential dietary supplement prevention underscore value development medicinal foods functional food applications.
Language: Английский
Citations
0Carbohydrate Polymers, Journal Year: 2025, Volume and Issue: 354, P. 123300 - 123300
Published: Jan. 20, 2025
Language: Английский
Citations
0Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)
Published: March 15, 2025
The cascade reaction of lipopolysaccharides (LPS), cell-free DNA (cfDNA), and reactive oxygen species (ROS), drives the development inflammatory bowel disease (IBD). Herein, we construct polyethylenimide (PEI)-L/D-tartaric acid (L/D-TA) complexes templated mesoporous organosilica nanoparticles (MON) (PEI-L/D-TA@MON) by mimicking biosilicification under ambient conditions within seconds. chiral nanomedicines include four functional moieties, wherein PEI electrostatically attracts cfDNA, tetrathulfide bonds reductively react with ROS, silanol groups adsorb LPS, L/D-TA enables recognition localization. Following oral administration, PEI-L-TA@MON exhibiting preferential conformation stereoscopically matches mucosa anchors onto intestine for lesion targeting. eliminates alleviating oxidative stress, inhibiting cascade, maintaining immune homeostasis to achieve IBD therapy. In addition, rapid synthesis, low cost, energy-free preparation, negligible toxicity, satisfactory therapeutic effect, facile conversion on modes will bring changes treatment, providing research values translational clinical prospects. Here, Xu et. al. composed moieties eliminate cfDNA targeted treatment IBD.
Language: Английский
Citations
0Aquaculture, Journal Year: 2025, Volume and Issue: unknown, P. 742427 - 742427
Published: March 1, 2025
Language: Английский
Citations
0